STAT+: Trump touts pharma deals to offer cheaper drugs to state Medicaid programs

Written and edited by the WorldPing NewsdeskPublished Updated Original reporting: STAT
STAT+: Trump touts pharma deals to offer cheaper drugs to state Medicaid programsWorldPing
Image via STAT.

What happened

Every state will participate in the GENEROUS program, but many of the details are unknown.

Key facts

  • Reported by STAT and published Fri, 18 Sep 2026 20:22:36 UTC.

Why it matters

Outbreaks, approvals and guidance changes have direct practical consequences for care, travel and public-health planning.

What to watch next

  • Case numbers and official guidance updates
  • Regulatory decisions in other countries
  • Supply, recall or access changes

Coverage timeline

When each newsroom published on this story, oldest first — all times UTC.

  1. STAT+: Pharmalittle: We’re reading about licensing deals with China, making drugs in space, and more

  2. STAT+: In a fight over denied claims, HCA sues out-of-state Blue Cross Blue Shield plan

  3. STAT+: Trump touts pharma deals to offer cheaper drugs to state Medicaid programs

Sources

The original report was published by STAT. WorldPing does not claim that reporting — this page summarises and contextualises it.

Read the full report at STAT

Follow the story

Living hubs that keep updating as this story develops.

Related WorldPing coverage